Questions linger regarding MindsEye's rushed release
The big Summer Games Fest weekend of live showcases and game previews is over, and here's what to expect in this week's game news recap.
The big picture
'A delayed game is eventually good, but a rushed game is forever bad' – a quote that still resonates in the games industry. Nowhere is that more evident than in the release of action-adventure open-world title MindsEye.
This highly touted game from ex-Rockstar Games producer Leslie Benzies's studio, Build A Rocket, promised a rich single-player narrative and ongoing user-generated content post-launch.
It was released on June 10, with not a single reviewer in the world receiving an early copy before launch – usually a red flag.
Sure enough, both early and late impressions from reviewers and content creators were largely negative. The game was buggy, unstable, and riddled with technical issues involving performance and artificial intelligence (AI). Its story also ended abruptly.
A large number of PlayStation owners refunded the game en masse – the last time this happened on such a scale was during Cyberpunk 2077's troubled PlayStation 4 launch in 2020.
The developers are now scrambling to patch the title, likely over the next several weeks, as it is – to quote the community – 'a car on fire'. It simply should not have been released in its current state, even with this relatively quiet sales window before the second half of 2025.
This raises a few lingering questions:
Who exactly was asking for another open-world action-adventure title that isn't Grand Theft Auto?
Did the ex-Rockstar producer contribute meaningfully to the earlier GTA titles? A seasoned veteran wouldn't have allowed a game to launch in such a state.
Short beats
ASUS Republic of Gamers is teaming up with Xbox to produce the ROG Xbox Ally (standard and X versions), a portable PC launching this holiday season.
The Outer Worlds 2 will be released on Oct 30 and will cost US$80 – part of the ongoing trend of triple-A titles surpassing the US$60 mark.
The animated superhero series Invincible is getting its own fighting game in 2026, developed by the same team behind the acclaimed Killer Instinct reboot (2013).
Resident Evil Requiem (aka Resident Evil 9) is Capcom's next survival horror entry, launching Feb 26, 2026 for PC and consoles.
Nintendo Switch 2 has outsold the original Switch by 3-to-1 during its launch in Japan.
No Straight Roads 2, from Malaysian studio Metronomik, will be published in 2026 in collaboration with Shueisha Games.
Upin & Ipin, the beloved Malaysian children's show, is getting an action-adventure game adaptation due later this year.
Marvel Mystic Mayhem, a mobile strategy game, is coming to iOS and Android on June 25.
Konami is remaking the original Silent Hill with Bloober Team, which also handled the Silent Hill 2 remake.
Games out this week
Berserk Or Die is a 2D indie action game where you control a berserker slaying Roman legionnaires from both flanks using keyboard-based combo inputs.
MindsEye is an open-world action-adventure game by Build A Rocket, led by former GTA producer Leslie Benzies.
Warhammer 40,000: Space Marine – Master Crafted Edition is a remaster of the 2011 sci-fi action title.
Wizard of Legend 2 is a roguelite sequel featuring 3D visuals and new combinable magic spells.
Recommended viewing
Here's a funny comparison between Mindseye and Grand Theft Auto: San Andreas (2004). Watch this insightful interview with RPG composer Yasunori Nishiki on crafting great game music.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Kate Beckinsale Sues ‘Canary Black' Producers for Negligence, Battery and ‘Unsafe' Set Conditions
Kate Beckinsale is suing the producers of her 2024 film Canary Black, Us Weekly can confirm. Beckinsale, 51, filed an amended complaint in Los Angeles Superior Court on May 21, per legal documents obtained by Us on Wednesday, June 11. She accuses Anton Entertainment and producer John Zois of negligence, battery and intentional infliction of emotional distress. The document alleges that Beckinsale 'was repeatedly exposed to unsafe and dangerous conditions' while filming the action thriller from late 2022 to early 2023, and as a result, suffered 'severe and debilitating injuries, including significant trauma to her left knee.' The complaint alleges that the actress and 'her team repeatedly raised red flags regarding unsafe conditions on and off set to Defendants, including long, dangerous set days, often lasting fifteen hours, inadequate equipment and medical personnel to help manage the high physical workload and recover from the exertion off set, and failure to adequately inform Ms. Beckinsale of what stunts she was expected to perform until often the moment she had to perform it." Kate Beckinsale Responds to Blake Lively Suit With Details of Her Own Mistreatment on Set Beckinsale's complaint alleges that producers ignored the red flags and "continued to recklessly and intentionally forge ahead with unsafe filming conditions, forgoing safety to maintain profit margins, and in the process, put [her] in harm's way." Originally, she filed the complaint in December, under the name Jane Doe. Her amended filing reveals emails between Beckinsale's team and Canary Black producers as well as additional information about her injuries, which included a complex meniscus tear in her left knee. "No one is actually taking real action to put a plan in place to fix this situation so it never happens again… [Beckinsale] keeps showing up to set for her call time and everyone around her has been made aware it's going to be a 15 hour [or more] day except for her,' Beckinsale's agent, Shani Rosenzweig, wrote in an email to Zois. The agent demanded swift action to address unsafe conditions, adding, "If you're trying to kill a person, you're doing a great job." Everything Celebrities Have Said About Working With Intimacy Coordinators on TV and Movie Sets Per the complaint, Zois responded, 'I don't know what else to say other than you're right.' He said "we need to shorten these days," agreeing that the pace was "not sustainable." However, the complaint alleges, "set conditions continued to be dangerous, with production staff routinely pushing [Beckinsale] to shoot for fifteen hour days, and perform dangerous action sequences, without pre-clearing or pre-training." In December 2022, Beckinsale injured her knee while filming an action scene. She underwent surgery and the production was delayed two months. She returned to set in February 2023, with a notice from her surgeon that she "could not do running, kicking, diving, or hanging from a harness, among other activities." The Canary Black team allegedly "disregarded" the notice and Beckinsale "suffered further injury, including aggravation and exacerbation of her existing injuries, which was entirely avoidable," per the complaint. Kate Beckinsale Claps Back at Trolls Questioning Her Weight Loss: 'Completely Unnecessary' Us has reached out to reps for Zois and Anton Entertainment for comment. Canary Black, which dropped on Prime Video in October 2024, stars Beckinsale as Avery Graves, a CIA operative whose husband is kidnapped by terrorists. In order to save her husband, she is tasked with betraying her own country. When the film was released, Beckinsale took to Instagram and posted multiple photos of injuries she endured from doing her own stunts on the set of the film. Each snap showed off a different injury, revealing various bruises and cuts on her arms, hands, fingers, knees and elbows.
Yahoo
3 hours ago
- Yahoo
ZIM Integrated (ZIM) Jumps as Geopolitical Tensions Expected to Benefit Operations
We recently published a list of . In this article, we are going to take a look at where ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) stands against other best-performing stocks of Friday. ZIM Integrated snapped a four-day losing streak on Friday, jumping by 5.67 percent to close at $17.51 apiece as investor sentiment was buoyed by positive developments from the US-China trade negotiations. ZIM Integrated Shipping Services Ltd. (ZIM), one of the 20 largest shipping companies globally, stands to benefit from the trade negotiation progress on expectations that it would spur global trade activities anew. A fleet of vessels docking at a busy harbor, signaling the company's presence in global marine shipping. Based on its 2024 annual report, a significant chunk of its operations originates from China, 'and therefore depends on the level of imports and exports to and from China.' Despite a challenging first quarter for ZIM Integrated Shipping Services Ltd. (NYSE:ZIM), the company still achieved a 227-percent jump in its net income attributable to shareholders of $295.3 million from the $90.3 million registered in the same period last year. Total revenues increased by 28.8 percent to $2.01 billion from the $1.56 billion registered in the same period last year, mainly driven by the increase in freight rates and carried volume. While we acknowledge the potential of ZIM as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
3 hours ago
- Yahoo
MRO acquires clinical data management platform Q-Centrix from TPG Growth
US-based clinical data exchange company MRO has acquired Q-Centrix, an enterprise clinical data management platform previously owned by TPG Growth. Q-Centrix is a comprehensive data management platform designed to reduce complexity, expedite decisions and advance clinical outcomes. MRO said the acquisition would enable hospitals and health systems to convert fragmented clinical data into actionable insights, expediting the exchange of clinical data across the sector. The deal is expected to create scalable value for healthcare providers, payers and life sciences, supporting more precise decision-making and broader clinical applications. MRO CEO Jason Brown said: 'At MRO, we believe there is tremendous untapped value in unlocking and leveraging clinical data that resides in fragmented, siloed systems today. 'Combining MRO's leading clinical data exchange solutions and Q-Centrix's clinical data management capabilities creates a category-defining, fit-for-purpose platform, enabling high fidelity, low latency acquisition, abstraction, curation and exchange of clinical data to power better patient care and reduce costs across the healthcare ecosystem.' The combined entity will provide services to more than 2,000 health systems and hospitals, as well as over 7,000 clinics and almost 250 payers. By enriching and curating clinical data, MRO and Q-Centrix aim to deliver scalable value, facilitating precise decision-making and wider clinical applications. Q-Centrix CEO Milton Silva-Craig said: 'MRO and Q-Centrix share a commitment to advancing the industry in service of our customers. 'That focus is fuelling the creation of a first-of-its-kind platform—seamlessly integrating systems and delivering structured, highly valuable data sets to support clinical care, operational performance, breakthrough research, and regulatory compliance. 'Purpose-built around our customers' most pressing needs, this is innovation where it matters most.' The acquisition is supported by healthcare technology investors such as private equity company Parthenon Capital, which has reaffirmed its support for MRO with a new investment. The parties have not disclosed the value of the deal. "MRO acquires clinical data management platform Q-Centrix from TPG Growth" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio